scholarly journals Toxoplasma gondii destroys Her2/Neu-expressing mammary cancer cells in vitro using a continuous feed medium approach

2020 ◽  
Vol 14 (10) ◽  
pp. 1204-1209
Author(s):  
Esra Atalay Şahar ◽  
Mert Döşkaya ◽  
Muhammet Karakavuk ◽  
Hüseyin Can ◽  
Aytül Gül ◽  
...  

Introduction: Toxoplasma gondii is an opportunistic protozoan and can be grown using several human cell lines. Breast cancer is the second leading cause of cancer death in women. Her2/Neu-expressing mammary cancer cell lines called TUBO can be grown in vitro. In recent years, protozoan parasites have become popular means of use in cancer therapy research. In this study, we analyzed whether T. gondii tachyzoites can destroy TUBO cells using a novel continuous feed medium approach. Methodology: Two sets of flasks (each containing four groups) containing TUBO cells were inoculated with T. gondii Ankara strain tachyzoites. First set containing 5×106 TUBO cells were inoculated with TUBO-tachyzoite ratios of 1:2, 1:1, 2:1, and 4:1 and second set containing 1×106 TUBO cells were inoculated with TUBO-tachyzoite ratios of 10:1, 100:1, 1000:1, and 2000:1. Thereafter, culture supernatants were harvested at various days until TUBO cells were destroyed and tachyzoites were counted. Results: In the first and second sets of flasks, TUBO cells were destroyed between days 8 to 12 and 12 to 25, respectively. In addition, the amount of tachyzoites increased 7- 43 and 595 to 112500 times in the first and second set of flasks, respectively. Conclusions: These results show that T. gondii tachyzoites successfully destroy Her2/Neu-expressing mammary cancer cells using a continuous feed medium approach. Although this idea may be too premature for the moment, the approach defined herein may support future researchers investigating the relationship between cancer and parasites which can make important progress toward saving cancer patient lives.

Cancers ◽  
2020 ◽  
Vol 12 (9) ◽  
pp. 2342 ◽  
Author(s):  
Lucie Brisson ◽  
Stéphanie Chadet ◽  
Osbaldo Lopez-Charcas ◽  
Bilel Jelassi ◽  
David Ternant ◽  
...  

The P2X7 receptor is an ATP-gated cation channel with a still ambiguous role in cancer progression, proposed to be either pro- or anti-cancerous, depending on the cancer or cell type in the tumour. Its role in mammary cancer progression is not yet defined. Here, we show that P2X7 receptor is functional in highly aggressive mammary cancer cells, and induces a change in cell morphology with fast F-actin reorganization and formation of filopodia, and promotes cancer cell invasiveness through both 2- and 3-dimensional extracellular matrices in vitro. Furthermore, P2X7 receptor sustains Cdc42 activity and the acquisition of a mesenchymal phenotype. In an immunocompetent mouse mammary cancer model, we reveal that the expression of P2X7 receptor in cancer cells, but not in the host mice, promotes tumour growth and metastasis development, which were reduced by treatment with specific P2X7 antagonists. Our results demonstrate that P2X7 receptor drives mammary tumour progression and represents a pertinent target for mammary cancer treatment.


2006 ◽  
Vol 105 (1) ◽  
pp. 29-36 ◽  
Author(s):  
John Yoonkeun Jun ◽  
James W. Griffith ◽  
Richard Bruggeman ◽  
Sharlene Washington ◽  
Laurence M. Demers ◽  
...  

2019 ◽  
Vol 15 (1) ◽  
Author(s):  
Consuelo Serrano ◽  
Sofía Guzmán ◽  
Jose Ignacio Arias ◽  
Cristian Gabriel Torres

Abstract Background Mammary cancer is a common disease affecting female dogs, where approximately 50% of the cases are malignant. There is a subpopulation of cancer cells with stem cell-like features within the tumour microenvironment, which can form in vitro spheres, cell structures that grow in anchor-free conditions. This cell population shows resistance to conventional antitumor treatments explaining in part the recurrence of some type of cancers. It has been previously reported that spheres derived from CF41.Mg canine mammary carcinoma cells exhibit several stemness features. Melatonin has shown antitumor effects on cancer mammary cells; nevertheless, its effects have been poorly evaluated on canine mammary cancer stem-like cells. In this regard, it has described that melatonin decreases the expression of OCT-4 in CMT-U2229 mammary cancer cells, a transcription factor that participates in the modulation of self-renewal and drug resistance in cancer stem-like cells. The aim of this study was to compare the effects of melatonin on viability and migration of canine mammary carcinoma CF41.Mg-spheres, and CF41.Mg-parental cells. CF41.Mg cells were grown in DMEM high-glucose medium containing 10% bovine foetal serum. CF41.Mg-spheres were cultured in ultra-low attachment plates with serum-free DMEM/F12 containing several growth factors. Cell viability (MTS reduction) and migration (transwell) assays were conducted in presence of melatonin (0.01, 0.1 or 1 mM). Results Melatonin decreased cell viability at 1 mM (P < 0.05), with a significant reduction in spheres compared to parental cells at 24 and 48 h (P < 0.05). Cell migration was inhibited in response to non-cytotoxic concentration of melatonin (0.1 mM) (P < 0.05) in spheres and monolayer of cells, no significant differences were detected between both cell subtypes. Conclusions These results indicate that melatonin reduces viability and migration of CF41.Mg cells, where spheres exhibit greater sensitivity to the hormone. Thus, melatonin represents a valuable potential agent against mammary cancer cells, especially cancer stem-like cells.


2012 ◽  
Vol 8 (1) ◽  
pp. 35 ◽  
Author(s):  
Magdalena Król ◽  
Karol M Pawłowski ◽  
Katarzyna Szyszko ◽  
Henryk Maciejewski ◽  
Izabella Dolka ◽  
...  

2012 ◽  
Vol 8 (1) ◽  
pp. 16 ◽  
Author(s):  
Magdalena Król ◽  
Karol M Pawłowski ◽  
Kinga Majchrzak ◽  
Małgorzata Gajewska ◽  
Alicja Majewska ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Pedro L. P. Xavier ◽  
Yonara G. Cordeiro ◽  
Pâmela A. Alexandre ◽  
Pedro R. L. Pires ◽  
Bruno H. Saranholi ◽  
...  

AbstractTargeting self-renewal and tumorigenicity has been proposed as a potential strategy against cancer stem cells (CSCs). Epigenetic proteins are key modulators of gene expression and cancer development contributing to regulation and maintenance of self-renewal and tumorigenicity. Here, we have screened a small-molecule epigenetic inhibitor library using 3D in vitro models in order to determine potential epigenetic targets associated with self-renewal and tumorigenicity in Canine Mammary Cancer (CMC) cells. We identified inhibition of BET proteins as a promising strategy to inhibit CMC colonies and tumorspheres formation. Low doses of (+)-JQ1 were able to downregulate important genes associated to self-renewal pathways such as WNT, NOTCH, Hedgehog, PI3K/AKT/mTOR, EGF receptor and FGF receptor in CMC tumorspheres. In addition, we observed downregulation of ZEB2, a transcription factor important for the maintenance of self-renewal in canine mammary cancer cells. Furthermore, low doses of (+)-JQ1 were not cytotoxic in CMC cells cultured in 2D in vitro models but induced G2/M cell cycle arrest accompanied by upregulation of G2/M checkpoint-associated genes including BTG2 and CCNG2. Our work indicates the BET inhibition as a new strategy for canine mammary cancers by modulating the self-renewal phenotype in tumorigenic cells such as CSCs.


Chemotherapy ◽  
2009 ◽  
Vol 55 (3) ◽  
pp. 175-182 ◽  
Author(s):  
Francisco N. Alvarez ◽  
Louise M. Carlson ◽  
Inna Lindner ◽  
Kelvin P. Lee

1993 ◽  
Vol 29 (14) ◽  
pp. 1958-1963 ◽  
Author(s):  
E.A. Bruyneel ◽  
G.A. Storme ◽  
D.C.C. Schallier ◽  
D.L. Van den Berge ◽  
P. Hilgard ◽  
...  

Oncogene ◽  
2004 ◽  
Vol 23 (5) ◽  
pp. 1125-1135 ◽  
Author(s):  
Peter K M Kim ◽  
Michaele Armstrong ◽  
Ye Liu ◽  
Peng Yan ◽  
Brian Bucher ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document